December 18, 2017 / 1:42 PM / a month ago

BRIEF-Ultragenyx Sells Priority Review Voucher For $130 Mln

Dec 18 (Reuters) - Ultragenyx Pharmaceutical Inc:

* ULTRAGENYX SELLS PRIORITY REVIEW VOUCHER FOR $130 MILLION

* ENTERED INTO A DEFINITIVE AGREEMENT TO SELL ITS RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER TO NOVARTIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below